2m 2m 2m 2m 2m 2m 2m
FULCRUM THERA (FULC)
NASDAQ
$3.84-$0.02 (-0.39%)
Price as of Jun 23, 2026 5:46 PM EDT- $251.2MMarket Cap
- -47.42%1-Year Change
- BiotechnologyIndustry
FULCRUM THERA (FULC)
$3.84-$0.02 (-0.39%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 0 -100.00% | 80.0M +2,752.05% | 2.8M -55.77% | 6.3M -66.90% | |
Cost of Revenue | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Gross Profit | 0 -100.00% | 80.0M +2,752.05% | 2.8M -55.77% | 6.3M -66.90% | |
Sales and Marketing Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Research and Development Expense | -56.1M -11.49% | -63.4M -11.72% | -71.8M -6.49% | -76.8M +10.16% | |
Depreciation and Amortization Expense | 1.4M -12.74% | 1.6M -26.66% | 2.2M -10.02% | 2.4M -4.02% | |
Total Operating Expenses | 84.8M -16.81% | 101.9M -10.20% | 113.5M -4.57% | 118.9M +18.65% | |
Operating Profit | -84.8M +287.13% | -21.9M -80.21% | -110.7M -1.69% | -112.6M +38.87% | |
Interest Income | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Total Nonoperating Income and Expense | 9.9M -18.76% | 12.2M -8.68% | 13.3M +395.50% | 2.7M +1,199.52% | |
Income before Taxes | -84.8M +287.13% | -21.9M -80.21% | -110.7M -1.69% | -112.6M +38.87% | |
Income Taxes | 0 N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | 0 N/A | 0 N/A | 0 N/A | 0 N/A | |
Net Income | -74.9M +669.97% | -9.7M -90.01% | -97.3M -11.41% | -109.9M +35.90% | |
Net Income from Continuing Operations Applicable to Common | -74.9M +669.97% | -9.7M -90.01% | -97.3M -11.41% | -109.9M +35.90% | |
Basic EPS and Net Income | -1.18 +637.50% | -0.16 -89.94% | -1.59 -34.84% | -2.44 +6.55% | |
Diluted EPS and Net Income | -1.18 +637.50% | -0.16 -89.94% | -1.59 -34.84% | -2.44 +6.55% | |
Basic Weighted Average Shares | 63,355 +2.21% | 61,984 +1.10% | 61,310 +36.27% | 44,991 +27.23% | |
Diluted Weighted Average Shares | 63,355 +2.21% | 61,984 +1.10% | 61,310 +36.27% | 44,991 +27.23% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 197.5M +239.33% | 58.2M +127.72% | 25.6M -27.17% | 35.1M -0.89% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 197.5M +239.33% | 58.2M +127.72% | 25.6M -27.17% | 35.1M -0.89% | |
Total Current Assets | 357.5M +43.04% | 249.9M +3.19% | 242.2M +16.71% | 207.5M -8.18% | |
Accumulated Depreciation | 15.6M +9.75% | 14.3M +11.73% | 12.8M +19.68% | 10.7M +28.94% | |
Property and Plant and Equipment and Net | 2.8M -27.59% | 3.9M -25.23% | 5.2M -24.47% | 6.9M -6.27% | |
Total Long-Term Assets | 538,000 +5,280.00% | 10,000 -99.50% | 2.0M -4.47% | 2.1M +288.38% | |
Total Assets | 366.3M +40.49% | 260.7M +1.17% | 257.7M +13.68% | 226.7M -3.54% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 13.0M +18.15% | 11.0M -19.24% | 13.7M -18.24% | 16.7M -12.89% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 197,000 0.00% | 197,000 0.00% | 197,000 0.00% | 197,000 -88.27% | |
Total Liabilities | 17.3M -2.26% | 17.7M -21.41% | 22.5M -18.89% | 27.7M +18.25% | |
Retained Earnings | -594.3M +14.42% | -519.4M +1.91% | -509.7M +23.61% | -412.3M +36.32% | |
Total Stockholders Equity | 349.0M +43.60% | 243.0M +3.33% | 235.2M +18.22% | 198.9M -5.95% | |
Total Shares Outstanding | 66.6M +23.37% | 54.0M -12.84% | 61.9M +18.84% | 52.1M +28.24% | |
Cash Flow | |||||
Cash from Operating Activities | -60.1M +2,608.07% | -2.2M -97.56% | -91.0M -6.27% | -97.0M +23.67% | |
Capital Expenditures | 314,000 +12.95% | 278,000 -45.28% | 508,000 -74.12% | 2.0M +14.59% | |
Cash from Investing Activities | 30.7M -4.69% | 32.2M +187.84% | -36.7M -395.59% | 12.4M +109.57% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 168.7M +6,042.28% | 2.7M -97.68% | 118.1M +40.08% | 84.3M -54.79% | |
Financials Ratio | |||||
Gross Margin | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Operating Margin | N/A N/A | -27.37% -99.31% | -3,945.24% +122.29% | -1,774.85% +319.61% | |
Return on Assets | -23.89% +536.63% | -3.75% -90.66% | -40.19% -15.56% | -47.60% +7.32% | |
Return on Equity | -25.30% +521.96% | -4.07% -90.93% | -44.84% -16.24% | -53.53% +1.55% | |
Revenue Growth | -100.00% -103.63% | 2,752.05% +5,034.54% | -55.77% -16.64% | -66.90% -157.09% | |
Current Ratio | 27.40 +21.07% | 22.63 +27.77% | 17.71 +42.74% | 12.41 +5.41% | |
Cash Ratio | 15.14 +187.22% | 5.27 +181.97% | 1.87 -10.92% | 2.10 +13.77% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow